Abstract:Macrophages play a critical role in innate and adaptive immunity, and the regulation of macrophage function in inflammatory disease treatment has been widely studied. Litsea cubeba is an important Chinese medicinal plant used for the treatment of inflammatory diseases. However, the inflammatory bioactive ingredients in L. cubeba and underlying molecular mechanisms are poorly understood. Herein, we first obtained and elucidated a novel isoquinoline alkaloid, Litcubanine A (LA), from L. cubeba . An in vitro study indicated that LA could significantly inhibit LPS-induced activation of inflammatory macrophages via the NF-κB pathway, leading to the decrease of inflammatory factors including iNOS, TNF-α, and IL-1β. Moreover, LA showed an inhibiting effect on the expression of NO in macrophages by directly binding to iNOS protein. Molecular simulation docking also demonstrated that active LA created an interaction with GLU 371 residue of iNOS via attractive charge derived from the N→O group, revealing its highly selective inhibition toward iNOS. By using the IκK inhibitor and iNOS inhibitor, these two regulatory targets of LA on inflammatory macrophages were verified in vitro . Finally, by using a caudal fin resection model in zebrafish larvae, and the skin wound healing model in mice, we proved in vivo that LA down-regulated the secretion of local inflammatory factors by inhibiting macrophage recruitment and activation at the early stage of the injury. Collectively, our study demonstrated that the novel isoquinoline alkaloid LA suppresses LPS-induced activation of inflammatory macrophages by modulating the NF-κB pathway, suggesting that inflammatory macrophage activation pathway is an effective target for inflammation treatment, and LA is a new pharmacophore for the development of novel and effective anti-inflammatory agents to regulate local macrophages.

N-alkylamides from Litsea Cubeba (lour.) Pers. with Potential Anti-Inflammatory Activity

Chemical Constituents with NO Production Inhibitory and Cytotoxic Activities from Litsea Cubeba.

Synthesis of the dibenzylbutane lignan LCA derivatives and evaluation of their anti-inflammatory activities

Vitual screening of 5-LOX inhibitors of amide compounds from Litsea plants based on novel drug design method

Antimicrobially Active Isoquinoline Alkaloids Fromlitsea Cubeba

Lignanamides from the Roots of Metternichia macrocalyx and Their Anti-inflammatory Activity

Chemical Constituents from the Roots and Stems of Litsea Cubeba

Anti-Inflammatory Constituents from the Root of Litsea Cubeba in Lps-Induced Raw 264.7 Macrophages

Two New Isoquinoline Alkaloids from Litsea Cubeba

Alkaloids from roots and stems of Litsea cubeba

Bioactive sesquineolignans from the twigs of Litsea cubeba

Two New Amides from Physochlainae Radix

Novel Isoquinoline Alkaloid Litcubanine A - A Potential Anti-Inflammatory Candidate

Three New Guaiane-Type Sesquiterpenoids and a Monoterpenoid from Litsea Lancilimba Merr

Phenolic Acids Derivatives from Meehania Fargesii with Anti‐inflammation Effects

Anti-inflammatory Activity of Two New Indole Alkaloids from the Stems of Nauclea officinalis

Chemical Constituents from the Heartwood of Solanum Verbascifolium L.And Their Anti‐Inflammatory Activities Combined Network Pharmacology

Three New Labdane‐type Diterpenoids from the Fruits of Amomum villosum and their Anti‐inflammatory Activities

An extensive pharmacological evaluation of novel anti-nociceptive and IL-6 targeted anti-inflammatory guaiane-type sesquiterpenoids from Cinnamomum migao H. W. Li through in-depth in- vitro , ADMET, and molecular docking studies

Hepialiamides A–C: Aminated Fusaric Acid Derivatives and Related Metabolites with Anti-Inflammatory Activity from the Deep-Sea-Derived Fungus Samsoniella Hepiali W7

Methyl 2-Naphthoates with Anti-Inflammatory Activity from Morinda Officinalis